Overall, investigation of the primary lung cancer tissues over advancing stages of the disease has confirmed the lung cancer cell line studies, supporting the roles of PKR, OAS, and IL-24 as specific lung cancer suppressor candidates, worthy of consideration for therapeutic strategies. This evidence concerns the gene EIF2AK2 and lung carcinoma.